Literature DB >> 32072856

Natural chemical entities from Arisaema genus might be a promising break-through against Japanese encephalitis virus infection: a molecular docking and dynamics approach.

V Navyashree1, Kamal Kant2, Anoop Kumar1.   

Abstract

Japanese encephalitis virus (JEV) infection affects millions of population worldwide whose incidence is increasing year by year and currently, no specific drugs are available for its treatment. However, vaccines are available for its prevention but not effective against all the clinical isolates. Thus, there is an urgent need for new chemical entities or exploration of existing molecules for its treatment. In the current study, we have undertaken virtual ligand screening (VLS) method to screen out selected phytoconstituents of Genus Arisaema against various targets (NS5, NS3 helicase, and NS2B-NS3 protease) of JEVs which exhibits vital role in replication, infection cycle and host interaction by using molecular docking followed by molecular dynamics (MD) simulations. Screened natural chemical entities displayed good binding affinity as well as optimum stability toward NS5 and NS3 helicase. Further, the drug likeliness evaluated by Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) analysis was found to be in the acceptable range. In conclusion, these natural chemical entities could be considered as promising candidates for the development of anti-JEV drugs. However, further investigation is required to confirm their exact role in JEV infection through in vitro and in vivo experiments.Communicated by Ramaswamy H. Sarma.

Entities:  

Keywords:  ADMET; Arisaema; Japanese encephalitis virus; molecular docking; molecular dynamics

Mesh:

Substances:

Year:  2020        PMID: 32072856     DOI: 10.1080/07391102.2020.1731603

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  3 in total

1.  Nα-1, 3-Benzenedicarbonyl-Bis-(Amino Acid) and Dipeptide Candidates: Synthesis, Cytotoxic, Antimicrobial and Molecular Docking Investigation.

Authors:  Ahmed M Naglah; Gaber O Moustafa; Ahmed A Elhenawy; Marwa M Mounier; Heba El-Sayed; Mohamed A Al-Omar; Abdulrahman A Almehizia; Mashooq A Bhat
Journal:  Drug Des Devel Ther       Date:  2021-03-25       Impact factor: 4.162

2.  Screening of phytoconstituents of Andrographis paniculata against various targets of Japanese encephalitis virus: An in-silico and in-vitro target-based approach.

Authors:  Shailesh Bhosale; Anoop Kumar
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-07-31

Review 3.  Antiviral drug research for Japanese encephalitis: an updated review.

Authors:  Shaun Joe; Abdul Ajees Abdul Salam; Ujjwal Neogi; Naren Babu N; Piya Paul Mudgal
Journal:  Pharmacol Rep       Date:  2022-02-19       Impact factor: 3.024

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.